Robert Simpson is an experienced litigation and trial lawyer and represents clients in state and federal courts throughout the country. He focuses on products liability litigation, with an emphasis on drug and medical device litigation, as well as toxic tort, employment and commercial disputes. His litigation practice has included multi-district litigation, class actions, mass torts and claims for unfair competition and false advertising.
Robert has been first or second chair trial counsel in more than twenty-five cases that have gone to trial. For the last five years he has served as lead trial counsel and national coordinating counsel for several significant medical device and pharmaceutical product liability cases for Johnson & Johnson and its subsidiaries relating to hip implants, pelvic mesh, NSAID and atypical antipsychotic medication litigation. In these high profile cases, Robert has managed all stages of pre-trial proceedings, taken and defended numerous expert and company witness depositions throughout the United States and Europe and has briefed and conducted Daubert and Frye challenges.
Robert serves as a member of the National Board of Directors of the American Board of Trial Advocates and a trial instructor for NITA and the ABA. He frequently gives presentations on e-discovery, the use of technology in the courtroom, deposition techniques and litigation management. He has held top leadership positions in the American Bar Association Litigation Section, the National Bar Association and the Connecticut Bar Association.
In a case on the Connecticut state court complex litigation docket, the owner of a large gasoline terminal sued our clients claiming antitrust violations, breach of contract, unfair trade practices, misrepresentation, and breach of the implied covenant of good faith and fair dealing. All of the plaintiff’s claims were disposed of before trial, and the case went forward solely on our clients' counterclaim for breach of contract. After two trials and two appeals, the court awarded our clients $5.5 million in damages and attorneys' fees.
View All »
Your e-mail and any information in your e-mail to this individual are
not protected by the attorney client privilege. Therefore your e-mail
should not contain any confidential information and should be for
general information purposes only. The e-mail to this individual is not
intended to create, and does not constitute, an attorney-client